IRIS
SPAGNUOLO, ROCCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.611
AS - Asia 1.672
EU - Europa 1.327
SA - Sud America 421
Continente sconosciuto - Info sul continente non disponibili 176
OC - Oceania 47
AF - Africa 45
Totale 6.299
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.502
SG - Singapore 720
IT - Italia 592
CN - Cina 320
BR - Brasile 316
DE - Germania 232
VN - Vietnam 216
GB - Regno Unito 141
IN - India 138
FI - Finlandia 110
CA - Canada 67
HK - Hong Kong 57
NL - Olanda 52
SE - Svezia 50
AR - Argentina 40
AU - Australia 39
BD - Bangladesh 25
ID - Indonesia 22
IR - Iran 22
MX - Messico 22
FR - Francia 20
EC - Ecuador 18
IQ - Iraq 18
KH - Cambogia 18
PL - Polonia 17
RO - Romania 15
MY - Malesia 13
RU - Federazione Russa 13
TR - Turchia 13
CL - Cile 12
CO - Colombia 12
ES - Italia 12
AT - Austria 11
TH - Thailandia 11
JP - Giappone 10
PK - Pakistan 10
KR - Corea 8
NZ - Nuova Zelanda 8
ZA - Sudafrica 8
ET - Etiopia 7
UA - Ucraina 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
IE - Irlanda 6
LV - Lettonia 6
MA - Marocco 6
PH - Filippine 6
PY - Paraguay 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
BO - Bolivia 5
EG - Egitto 5
GR - Grecia 5
JM - Giamaica 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
YE - Yemen 5
DK - Danimarca 4
DZ - Algeria 4
LT - Lituania 4
NP - Nepal 4
TN - Tunisia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
CY - Cipro 3
DO - Repubblica Dominicana 3
HR - Croazia 3
LB - Libano 3
PE - Perù 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
BY - Bielorussia 2
CU - Cuba 2
EU - Europa 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BJ - Benin 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
GA - Gabon 1
GD - Grenada 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LC - Santa Lucia 1
MD - Moldavia 1
Totale 6.124
Salva come PNG Salva come JPEG
Città #
San Jose 416
Ashburn 297
Singapore 295
Chandler 191
Dallas 180
Munich 176
Santa Clara 116
Council Bluffs 102
Milan 97
Ho Chi Minh City 95
Bengaluru 94
Hefei 91
New York 72
Chicago 71
Los Angeles 68
London 63
Helsinki 61
Beijing 60
Catanzaro 60
Hong Kong 53
Lawrence 50
Princeton 50
Turku 41
Boardman 40
São Paulo 38
Hanoi 35
San Francisco 35
Rome 32
Wilmington 23
Edinburgh 22
Denver 20
Orem 20
Montreal 19
Phnom Penh 18
Des Moines 16
Rio de Janeiro 16
Phoenix 15
Sydney 14
Toronto 13
Amsterdam 12
Brooklyn 12
Mexico City 11
Palermo 11
Redwood City 11
Atlanta 10
Boston 10
Chennai 10
Nuremberg 10
Redmond 10
Turin 10
Warsaw 10
Hamilton 9
Houston 9
Biên Hòa 8
Christchurch 8
Miami 8
Naples 8
San Nicola Manfredi 8
Shanghai 8
Taranto 8
Tokyo 8
Adelaide 7
Bari 7
Belo Horizonte 7
Brisbane 7
Buffalo 7
Campinas 7
Da Nang 7
Florence 7
Fortaleza 7
Guangzhou 7
Guayaquil 7
Hanover 7
Hải Dương 7
Kingston 7
Mumbai 7
Washington 7
Brasília 6
Campo Bom 6
Hortolândia 6
Jakarta 6
Norwalk 6
Ottawa 6
Pattaya 6
Perth 6
Riga 6
Seattle 6
Bắc Giang 5
Catania 5
Collegeville 5
Curitiba 5
Delhi 5
Dhaka 5
Dublin 5
Goiânia 5
Horia 5
Jyväskylä 5
La Plata 5
Manchester 5
Olomouc 5
Totale 3.621
Salva come PNG Salva come JPEG
Nome #
BETA-GLUCAN, INOSITOL AND DIGESTIVE ENZYMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ASSOCIATED WITH IRRITABLE BOWEL SYNDROME 632
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 310
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 256
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells. 143
Patient Reported Outcomes come strumento infermieristico nella gestione delle Malattie Infiammatorie Croniche Intestinali (MICI): Sintomi Gastrointestinali e Alterazioni Psicosociali. 80
Anti interleukin 12/23 in the treatment of erythema nodosum and Crohn disease: A case report. 78
DIAPHRAGMATIC REHABILITATION IN GASTROOESOPHAGEAL REFLUX DISEASE 78
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 78
COVID-19 Vaccine Booster Shot Preserves T Cells Immune Response Based on Interferon-Gamma Release Assay in Inflammatory Bowel Disease (IBD) Patients on Anti-TNFα Treatment 77
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 76
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 76
Acceptability of endoscopic procedures and patients' willingness to repeat them: a single-centre nursing study of influential factors 76
COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey 74
The role of gluten-free diet in nonalcoholic fatty liver disease development 74
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review Update 73
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 73
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study 72
Effects of a Portfolio-Mediterranean Diet and a Mediterranean Diet with or without a Sterol-Enriched Yogurt in Individuals with Hypercholesterolemia 72
COMPARISON BETWEEN DIFFERENT BOWEL PREPARATION REGIMENS FOR COLONOSCOPY: A SINGLE-CENTRE STUDY 69
Safety profile of intravenous iron in inflammatory bowel disease: an up-to-date overview 69
L’epatopatia alcolica: dal danno alla terapia 68
Case Report: A Migrating Stitch in a Crohn’s Disease Patient 68
Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome 66
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 66
OUTCOME OF ARTHRALGIA IN A SUBGROUP OF INFLAMMATORY BOWEL DISEASE PATIENTS WITH ANTI-TNF-ALPHA. A SINGLE CENTRE STUDY 66
Nursing-sensitive outcomes in adult inflammatory bowel disease: A systematic review 64
Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases 63
Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: Results from a multicenter randomized double-blind placebo-controlled gluten challenge 62
Exome-wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated with Fatty Liver Disease 62
Impact of Nursing Interventions via Telephone and Email on the Quality of Life of Patients with Inflammatory Bowel Disease: Preliminary Results of a Comparative Observational Study 61
Adaptation of the European Crohn's Colitis Organisation quality of care standards to Italy: The Italian Group for the study of inflammatory bowel disease consensus 60
Deregulation of SGK1 in Ulcerative Colitis: a paradoxical relationship between immune cells and colonic epithelial cells 60
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 59
Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study 59
C-reactive protein induces tissue factor expression and promotes smooth muscle cells and endothelial cell proliferation 59
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 59
Psychometric evaluation of an Italian custom 4-item short form of the PROMIS anxiety item bank in immune-mediated inflammatory diseases: An item response theory analysis 59
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies 58
Nursing issues in enteral nutrition during prone position in critically ill patients: A systematic review of the literature 58
Weight Gain and Liver Steatosis in Patients with Inflammatory Bowel Diseases 58
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 57
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 56
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 56
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study 55
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes. 55
Nursing communication as a tool for patient satisfaction. A single hospital survey 55
OBSERVING THE INFLUENCE OF SHAME AND GUILT IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW 54
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 54
The role of Neopterin in cardiovascular disease 54
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 54
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 54
W1173 An In Vivo Study to Evaluate {MLCK} Expression in Patients with Inflammatory Bowel Diseases 53
Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay 53
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 52
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores 52
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. 52
The effects of stress on gut virome: Implications on infectious disease and systemic disorders 51
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 51
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 50
Switching rate from intravenous to subcutaneous vedolizumab in managing inflammatory bowel diseases is lower than expected 50
Visualization of Comorbidities in Inflammatory Bowel Diseases through Networks 49
Lived Experiences of Patients With Inflammatory Bowel Disease in Italy: A Phenomenological Investigation 49
Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report 48
Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study 48
Pyoderma Gangrenosum and inflammatory bowel disease: a combined medical and surgical approach - case report and literature review 48
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 48
Surgery for a gastric Dieulafoy's lesion reveals an occult bleeding jejunal diverticulum. A case report. 47
Multifaceted pathogenesis of liver steatosis in inflammatory bowel disease: A systematic review 47
Effect of excess body weight on the genetic susceptibility to cancer. 46
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 46
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE study 45
HIGH DIAGNOSTIC YIELD OF HISTOLOGICAL ANALYSIS OF EUS FINE-NEEDLE ASPIRATION BIOPSY INCLUDED IN FORMALIN WITHOUT ON-SITE CYTOPATHOLOGIC EXAMINATION. A RETROSPECTIVE STUDY 44
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma 43
Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era 43
Pro-atherothrombotic effects of sigarette smoking in endothelial cells. Protective effects of statins 43
Use of biosimilars in inflammatory bowel disease: A position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 41
Can dysmetabolic comorbidities carry hepatic fat accumulation in patients with inflammatory bowel diseases? 40
Milk thistle, Sylibum marianum 40
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study 40
Esophageal rupture after Heimlich maneuver: a case report and literature review 39
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 39
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study 38
Milk Thistle, Silybum marianum 37
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 34
MBOAT7 in liver and extrahepatic diseases 33
Gastrointestinal symptoms of and psychosocial changes in inflammatory bowel disease: A nursing-led cross-sectional study of patients in clinical remission 33
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study 32
Cross talk between liver and adipose tissue: A new role for PNPLA3? 30
Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD) 29
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 26
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 26
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic Features 25
Functional disorders of the upper digestive tract: epidemiological, clinical and therapeutic aspects 21
A Case of a Neuroendocrine Tumor in a Liver Transplant Patient: Diagnostic and Management Difficulties 21
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study 21
107 Results From the {\textquotedblleft}{GLUTOX}{\textquotedblright} Trial: A Randomised, Double Blind, Placebo Controlled Crossover Study on {\textquotedblleft}Non Celiac Gluten Sensitivity{\textquotedblright} 17
Interleukin 23: Pathogenetic Involvement and Therapeutic Target for Ulcerative Colitis 17
Current management of acute severe ulcerative colitis in Italy: Results from an IG-IBD survey 15
Impact of Endoscopic Band Ligation on Gastric Complications Associated with Portal Hypertension 14
Upadacitinib’s Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study 13
Totale 6.254
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.079
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022201 0 1 6 41 16 8 9 39 15 35 22 9
2022/2023672 104 52 23 64 56 47 19 73 86 47 64 37
2023/2024552 94 68 49 32 41 94 25 44 22 14 15 54
2024/20251.288 139 41 39 44 94 148 127 77 158 41 144 236
2025/20263.123 168 276 309 414 280 134 365 170 291 194 454 68
2026/2027201 65 136 0 0 0 0 0 0 0 0 0 0
Totale 6.299